Real-world comparative effectiveness of SARS-CoV-2 primary vaccination campaigns against SARS-CoV-2 infections: a federated observational study emulating a target trial in three nations
European Journal of Public Health · 14.03.2026 · 36 (2)
DOI: 10.1093/eurpub/ckaf247 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Public Health, online erschienen am 07.01.2026. Verfasst von Marjan Meurisse und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccine Efficacy, Immunization Programs. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BY-COVID, Horizon Europe funded project from the European Union.
Abstract (Originalsprache)
To assess the impact of large-scale severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination campaigns in real-world settings across regions, we performed a reproducible cross-border comparison of the real-world effectiveness of primary vaccination in preventing SARS-CoV-2 infections across three sites: Aragon (Spain), Brussels and Wallonia (Belgium), and Finland. This observational study emulated a target trial by daily matching primary vaccinated individuals 1:1 to un- or partially vaccinated individuals using propensity scores estimated on a set of relevant confounders from January to September 2021. Matched individuals were followed up until a SARS-CoV-2 infection was contracted or a censoring event occurred. Vaccine effectiveness in preventing infections was estimated by the difference in restricted mean survival time (RMST). Primary vaccination extended the average free-of-infection time by 35.9 [95% confidence interval (CI) (34.9–37.0)], 59.6 [95% CI (59.3–60.0)], and 1.6 [95% CI (1.1–2.0)] days over 365 days in the population cohort of Aragon (Spain), Brussels and Wallonia (Belgium), and Finland, respectively. This federated population-based observational study showed the effectiveness of the SARS-CoV-2 primary vaccination campaign in prolonging the mean time to infection in the Aragon (Spain) and Brussels and Wallonia (Belgium) population cohorts. Only a minor difference over this time frame was found in Finland’s population cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
- Institut de Recherche Expérimentale et Clinique (IREC)-EPID, Université Catholique de Louvain, Brussels, Belgium.
- Data Science for Health Services and Policy, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
ORCID-Profile: Francisco Estupiñán-Romero, Markus Perola, Enrique Bernal-Delgado
Förderung
- BY-COVID
- Horizon Europe funded project from the European Union
Zitieren
APA
Meurisse, M., Estupiñán-Romero, F., Perola, M., Paajanen, T., González-Galindo, J., Van Goethem, N., & Bernal-Delgado, E. (2026). Real-world comparative effectiveness of SARS-CoV-2 primary vaccination campaigns against SARS-CoV-2 infections: a federated observational study emulating a target trial in three nations. European Journal of Public Health, 36(2). https://doi.org/10.1093/eurpub/ckaf247
Vancouver
Meurisse M, Estupiñán-Romero F, Perola M, Paajanen T, González-Galindo J, Van Goethem N, et al. Real-world comparative effectiveness of SARS-CoV-2 primary vaccination campaigns against SARS-CoV-2 infections: a federated observational study emulating a target trial in three nations. European Journal of Public Health. 2026;36(2). doi:10.1093/eurpub/ckaf247
BibTeX
@article{Meurisse2026,
author = {Meurisse, Marjan and Estupiñán-Romero, Francisco and Perola, Markus and Paajanen, Teemu and González-Galindo, Javier and Van Goethem, Nina and Bernal-Delgado, Enrique},
title = {Real-world comparative effectiveness of SARS-CoV-2 primary vaccination campaigns against SARS-CoV-2 infections: a federated observational study emulating a target trial in three nations},
journal = {European Journal of Public Health},
year = {2026},
volume = {36},
number = {2},
doi = {10.1093/eurpub/ckaf247}
}
EUVIMED